Sermorelin vs TRT: Does Sermorelin Increase Testosterone?
Sermorelin vs TRT comes down to one fact: they work on different hormones. Sermorelin prompts your pituitary gland to release more growth hormone. TRT gives you testosterone. In the studies we traced, none showed sermorelin alone raising testosterone in men. So when low testosterone is properly confirmed, sermorelin is not a substitute for TRT.
Here's the part most pages skip. The study clinics most often point to as proof that sermorelin "boosts testosterone"? Every man in it was already taking testosterone. We'll show you the numbers below.
What changes the answer:
- Your low T hasn't been confirmed yet? A diagnosis needs symptoms or signs plus consistently low testosterone, usually confirmed with a repeat early-morning fasting test.
- You want kids in the near term? TRT can suppress sperm production. Talk with a fertility-aware urologist or reproductive urologist before starting testosterone.
- Your evaluation does not confirm low testosterone? TRT is not indicated just because you feel tired, flat, or low-drive. Compounded sermorelin is not FDA-approved and has thin evidence for the wellness uses commonly marketed to adults.
TRT may be the right conversation if: you have symptoms or signs plus consistently low testosterone on appropriate testing, and a clinician has evaluated the cause, risks, and your fertility plans.
Sermorelin is not for you if: you're hoping it will fix confirmed low testosterone, protect fertility while treating low T, or stand in for a diagnosis you haven't gotten yet.
TRT Provider Guide is the independent decision resource for testosterone replacement therapy — helping U.S. adults understand how low testosterone is evaluated, compare online and local care models and providers, and choose the next step that fits their health needs, fertility plans, budget, state, and care preferences, with every material claim verified and dated.
This page is educational information, not medical advice. It covers adult men. If you have chest pain, severe trouble breathing, or signs of a stroke, call 911.
Disclosure: TRT Provider Guide may earn a commission from clearly labeled paid links for Male Excel and Hone Health. That never changes our verdict. On this page, many readers should not choose a provider yet. Read our affiliate disclosure.
Does sermorelin increase testosterone?
No study we traced shows sermorelin alone raising testosterone in men. Sermorelin acts on the growth-hormone pathway and can raise growth hormone and, in some studies, IGF-1. The testosterone claims you see online trace back mainly to a study of men already on testosterone, or to animal research that did not give the animals sermorelin.
First, a quick map of what sermorelin actually does.
Your brain makes a signal called growth hormone-releasing hormone (GHRH). It tells your pituitary gland — a pea-sized gland at the base of your brain — to release growth hormone (GH). Growth hormone then signals tissues including the liver and can increase IGF-1, a blood marker used when doctors evaluate the growth-hormone system.
Sermorelin is a lab-made version of the first 29 amino acids of GHRH. It presses the "growth hormone" button.
Testosterone runs on a different circuit. Your pituitary sends luteinizing hormone (LH) to your testicles, and your testicles make testosterone. Sermorelin is not designed to press that button. TRT supplies testosterone from outside the body.
That's the whole reason "sermorelin vs TRT" isn't a gentle-vs-strong choice. They're two different tools for two different hormone systems.
What the studies actually tested
We pulled the studies most often used to discuss GHRH or sermorelin-like treatment in older men, then checked who was in each study, what they actually took, and what was measured.
The scorecard: five commonly cited studies checked, zero establishing that sermorelin alone raises testosterone in a man.
That doesn't prove sermorelin could never move a testosterone number. It means the evidence does not establish sermorelin as a testosterone-raising treatment, and you should not pay for a promise the research hasn't shown.
The study everyone cites — and why it doesn't mean what you've heard
The 2017 Sigalos study 4 is the one you'll often see behind claims like "sermorelin boosts testosterone."
Look at who was in it. Every man was already receiving testosterone therapy. On top of that, they received three growth-hormone secretagogues, not sermorelin alone.
Two more details matter:
- The group shrank fast. Fourteen men were included, and later time windows had fewer observations.
- LH and FSH were low. Those are pituitary signals involved in testicular testosterone and sperm production. The authors did not find a statistically significant change, so the numbers should not be treated as proof of a mechanism.
The study does show a rise in IGF-1. That's a growth-hormone-system result. It does not establish sermorelin as a substitute for TRT.
The citation that leads to a mouse
A 2020 review on growth-hormone secretagogues 6 discusses animal evidence for testosterone effects and cites a growth-hormone-deficient animal study.
We tracked down the cited paper 5. It used dwarf mice, not men, and the mice received growth hormone or IGF-1 — not sermorelin. The study looked at testicular LH receptors and steroidogenic response to hCG.
We're not saying the review's authors acted in bad faith. Citations drift. But this is how a narrow preclinical finding can become a much broader marketing claim. When a clinic says "studies show," ask which study, who was in it, and what they actually took.
Sermorelin vs TRT: what's the real difference?
TRT replaces testosterone when a clinician has confirmed testosterone deficiency and treatment is appropriate. Sermorelin stimulates a different hormone pathway. They differ in what they target, what diagnosis comes first, how they're regulated, what evidence supports them, and what they can mean for fertility.
Two terms worth knowing:
- FDA-approved means the FDA reviewed that exact drug product under an approval pathway before marketing.
- Compounded means a licensed compounder prepares a drug for a patient or permitted clinical need under compounding law. Compounded drugs are not FDA-approved, and FDA does not review them for safety, effectiveness, or quality before marketing 10.
The right TRT provider is not the same for every person — it depends on whether low testosterone has been properly evaluated, your symptoms and health history, your fertility plans, your state, your insurance or cash-pay preference, your treatment-format preference, your budget, and whether online or in-person care is the better starting point. Some situations belong with primary care, urology, endocrinology, reproductive urology, or urgent or emergency care when the symptoms warrant it. Because a general answer cannot resolve those for you, use TRT Provider Guide's Find My TRT Path tool to map your situation to the right care route and the questions to ask before you pay.
Not sure yet whether your issue is testosterone, something else, or nothing that needs a prescription? Use Find My TRT Path →
Sermorelin or TRT: which fits your situation?
Your situation decides this, not a marketing page. Confirmed testosterone deficiency can make TRT a treatment to discuss. One low test means more evaluation first. Fertility plans, a possible pituitary problem, obesity-related low testosterone, or a normal result can send you down a different care route.
Find your row:
What "confirmed low testosterone" actually means
You need clinical symptoms or signs and consistently low testosterone measured accurately. Not one or the other.
The American Urological Association says a total testosterone below 300 ng/dL is a reasonable cutoff that can support the diagnosis, but it also says the diagnosis should be made only after two separate early-morning total testosterone measurements 7. The Endocrine Society says symptoms alone are not diagnostic and recommends at least two early-morning, fasting testosterone tests using accurate, standardized assays 8.
That does not make 300 ng/dL a universal diagnosis by itself. Lab method, repeat results, symptoms, free testosterone when indicated, medications, obesity, pituitary or testicular disease and other causes can change the evaluation.
Here's why this matters for sermorelin vs TRT. Tired, low drive and body-composition changes can occur with low testosterone. They can also come from poor sleep, depression, thyroid disease, obesity, medication effects, alcohol use and other conditions. A symptom quiz cannot tell you which hormone — if any — is the problem.
Is sermorelin FDA-approved?
No current sermorelin product is FDA-approved. The branded drug Geref had FDA approvals for a diagnostic use and for pediatric growth-hormone deficiency, but both products were discontinued and their approvals were later withdrawn at the manufacturer's request. FDA later determined they were not withdrawn for safety or effectiveness reasons 9.
Here's the timeline from FDA records 9:
- 1990: Geref 0.05 mg was approved as a diagnostic agent to evaluate pituitary growth-hormone secretion.
- 1997: Geref 0.5 mg and 1.0 mg were approved to treat children with growth failure due to idiopathic growth-hormone deficiency.
- 2008: EMD Serono told FDA it was discontinuing the products and requested withdrawal.
- 2009: FDA withdrew the approvals, effective June 18.
- 2013: FDA determined the products had not been withdrawn from sale for reasons of safety or effectiveness.
The treatment approval was pediatric. Neither approval established sermorelin as a treatment for adult low testosterone, anti-aging, energy, muscle gain, fat loss, or general "optimization."
That 2013 finding sometimes gets stretched into "sermorelin is FDA-approved" or "FDA proved it safe." It means neither discontinued Geref product was removed from sale because of safety or effectiveness concerns. It does not make today's compounded sermorelin FDA-approved.
The product matters on the TRT side, too. Multiple testosterone products are FDA-approved. Some telehealth programs also prescribe compounded testosterone. Those are different categories. Ask for the exact drug, formulation, manufacturer or compounder, and dispensing pharmacy before you pay.
What about the 2026 peptide policy news?
A pending peptide-compounding policy is not the same thing as drug approval. On October 14, 2026, an FDA item titled Interim Access Policy for Compounding Using Certain Peptides was submitted for federal regulatory review and remained pending as of this page's verification date 15.
Whatever the final policy says, a compounding enforcement or access policy does not turn compounded sermorelin into an FDA-approved drug. FDA continues to state that compounded drugs are not FDA-approved and do not undergo FDA premarket review for safety, effectiveness, or quality 10.
Is sermorelin safer than TRT?
Nobody has tested sermorelin and TRT head to head for overall safety. TRT has a much larger evidence base, established product labeling and known monitoring needs. Long-term safety evidence for compounded sermorelin used in otherwise healthy adults for wellness or "anti-aging" is far thinner. Less evidence is not the same as safer.
Sermorelin: what we know and don't know
- Short studies were small. The 6-week Vittone study 2 reported no significant adverse effects, but it involved only 11 older men.
- Adult wellness use is not an approved indication. Geref's treatment approval was for children with growth failure due to growth-hormone deficiency 9.
- Growth-hormone anti-aging therapy is not established routine care. The Endocrine Society has warned against using growth-hormone-axis treatment as an anti-aging strategy without an established medical indication 16.
- Compounded-drug quality is a separate issue. FDA warns that poor compounding can cause contamination or too much or too little active ingredient 10.
TRT: known risks you can monitor
- Blood pressure. In February 2025, FDA required or recommended class-wide labeling changes reflecting blood-pressure findings from postmarket studies 17.
- Heart attack and stroke. FDA removed boxed-warning language about increased major cardiovascular risk after reviewing TRAVERSE; the trial did not show a meaningful difference in major adverse cardiovascular events between testosterone and placebo groups 17.
- Higher hematocrit. Testosterone can raise red blood cell concentration, which is one reason clinicians monitor hematocrit.
- Skin transfer with topical products. Testosterone gels and some topical preparations can expose partners or children through skin contact if label precautions are not followed.
- Sperm suppression. Exogenous testosterone can lower or stop sperm production in some men 12.
- Labeling remains under review. In June 2026, FDA requested further testosterone-label updates concerning age-related hypogonadism, prostate cancer risk language and benign prostatic hyperplasia 18. A request for label changes should not be described as if every product label already contains the new wording.
Good TRT care includes follow-up after treatment starts, assessment of response and adverse effects, and appropriate laboratory monitoring 78.
Thinking about health history? Read who should not take TRT before you choose a provider.
What if you want kids someday?
Talk about fertility before you start TRT, not after. Testosterone from outside your body can suppress LH and FSH, the pituitary signals involved in testicular testosterone and sperm production. Sermorelin is not a proven way around that.
Sperm production can fall substantially during exogenous testosterone use, and some men can become azoospermic, meaning no sperm are seen in the semen sample 12.
Recovery after stopping testosterone varies. Many men recover sperm production over time, but the timing and degree of recovery are not guaranteed for any individual. A fertility plan should not rely on a promise that sperm counts will return by a certain date.
Where does sermorelin fit? Not as an established fertility treatment. It has not been shown to preserve fertility during TRT, and it is not an evidence-based substitute for treating confirmed testosterone deficiency.
If fertility matters in the near term, start with a urologist or reproductive urologist. Clinicians may discuss non-testosterone medicines in selected patients, but hCG, clomiphene and enclomiphene are not TRT and are not interchangeable. See hCG vs enclomiphene.
Can you take sermorelin and TRT together?
Some clinics prescribe both, but no controlled trial shows that adding sermorelin to TRT improves the outcomes patients usually care about. The published human combination evidence we found is a small retrospective study of men already on testosterone who also received three growth-hormone secretagogues 4.
If you're already on TRT and your clinic suggests sermorelin, ask:
- What problem is this for? Recovery? Sleep? Body composition? A documented growth-hormone disorder? Name the problem.
- What evidence supports this use? Ask for the study, not just a claim that "peptides work."
- How will we know it's working? What symptom or lab will be measured, and when?
- When do we stop? If the goal is not met, what is the stopping rule?
- What does it add to my bill? Get the medication, membership, lab, consult and shipping charges in writing.
At Hone Health, current public pages list standalone async sermorelin at $175/month without a membership or $130/month for eligible members, while testosterone cypionate starts at $28/month plus the applicable TRT membership and testing pathway 192021. That means the add-on can be a meaningful recurring cost even before any extra testing or plan-specific charges.
A higher bill does not prove the add-on is wrong. It does make the evidence question more important.
How much does sermorelin cost vs TRT?
Current published cash-pay prices vary more by care model than the drug name alone. In the programs we checked on October 23, 2026, a low advertised TRT medication price can sit on top of testing and membership fees, while compounded sermorelin is commonly sold as a separate monthly cash-pay medication.
We calculated the figures below from current public provider pages. They are published-price models, not personal quotes.
How we did the math
- Hone Plus: $45 initial + $45 confirmatory + ($135 membership + $28 testosterone) × 12 = $2,046
- Hone Premium: $65 initial + $25 confirmatory + ($155 membership + $28 testosterone) × 12 = $2,286
- Hone async sermorelin: $175 × 12 = $2,100
- Hone Basic + member sermorelin: $25 onboarding + ($25 membership + $130 medication) × 12 = $1,885
- Male Excel injectable starting model: $99 initial + ($99 membership + $120 advertised injection package) × 12 = $2,727, before shipping/handling
Costs people forget:
- Membership on top of medication.
- Confirmatory testing before TRT.
- Shipping and supplies when they are not included.
- Dose changes.
- Extra medicines bundled into or added to a plan.
- Commitment and cancellation terms.
Want the full breakdown for sermorelin alone? See our sermorelin cost guide.
Your low T is confirmed: where can you start TRT?
If low testosterone has been properly diagnosed and testosterone therapy is appropriate for you, the next choice is the care model — not sermorelin. Primary care, urology and endocrinology can all be reasonable starting points. Online TRT programs can also be an option when they are licensed for your state and their testing process fits your clinical situation.
If insurance coverage matters, start with your own doctor or a local urologist and your insurer's network. If cash-pay telehealth fits your needs better, compare the complete first-year bill, repeat-testing process, clinician access, treatment format, exact medication, pharmacy disclosure, fertility handling, monitoring, cancellation and records access.
Two online programs with current paid relationships on TRT Provider Guide
The commercial relationship does not make either provider the right fit for you. These are examples to compare after low testosterone has been evaluated.
Male Excel
Published strengths: Male Excel lists a $99 monthly membership with provider access, 60-day assessments and blood testing every six months. Its current pricing page lists injectable testosterone packages from $120/month and topical cream from $132/month, plus the required membership and shipping/handling 23.
The limitation to understand: the advertised injectable package includes thyroid medication, and Male Excel's public site also says clinicians may sometimes prescribe based on symptoms and health history before lab results arrive. For a new low-testosterone diagnosis, ask exactly how the program confirms consistently low morning testosterone before testosterone is prescribed. Our standard is the guideline-based diagnostic process described above.
State access: Male Excel currently says it does not prescribe hormone treatment in Alabama, Alaska, Arkansas, Connecticut, Hawaii, Idaho, Louisiana, Minnesota, Mississippi, New Hampshire or Rhode Island 25.
If Male Excel's care model fits what you're looking for: review the current Male Excel cost and testing details before you start →
Hone Health
Published strengths: Hone's Plus plan is built specifically around men's hormone care and publishes a repeat-test process before TRT, including a second testosterone measurement plus safety labs when TRT is being considered 20. Current membership pricing is $135/month for Plus and $155/month for Premium; testosterone starts at $28/month 192021.
The limitation to understand: Hone's own pages do not always use the same testing prices or units for medication pricing, and state availability varies by plan. Treat every public figure as a starting model and confirm your exact checkout before paying.
If published testing and price visibility matter most to you: review Hone's current plans, lab schedule and pricing conflicts →
What we actually verified
Date: October 23, 2026
Current provider pages checked: Male Excel pricing, TRT, homepage and FAQ pages; Hone membership overview, Plus, Premium, TRT and async-care pages; Taurus Meds homepage.
Verified as currently published:
- Male Excel's $99 initial test/consult, $99 monthly membership, $120 starting injectable package, $132 starting cream package, 11-state hormone-treatment exclusion list, 60-day assessments and six-month blood testing 2325.
- Hone's $135 Plus and $155 Premium membership prices, plan-specific initial and confirmatory testing, testosterone starting at $28/month, member sermorelin at $130/month, and standalone async sermorelin at $175/month 19202122.
- Taurus's homepage currently advertises a free starting testosterone test but does not publish a complete recurring TRT price on the public homepage text we reviewed 24.
Provider-stated, not independently tested: actual service delivery, final patient bills, turnaround times, program outcomes and whether a given medication or format will be prescribed to an individual.
Could not confirm from public pages: a patient-specific pharmacy assignment and final medication product for any provider; a complete current Taurus TRT bill and commitment from its homepage; whether every published treatment is available in every state.
Not done: We did not enroll, submit health information, complete checkout, contact support, receive medication or test any product. This is a public-source audit, not a hands-on review.
Your testosterone is normal: should you try sermorelin?
If a proper evaluation does not show testosterone deficiency, TRT is not a treatment for nonspecific symptoms. Sermorelin is a separate, compounded, non-FDA-approved option that some clinics market for recovery, sleep, body composition or "healthy aging," but the human evidence for those broad wellness promises is limited.
If your testosterone is not consistently low and you still feel off, the feeling is real. It just may not be a testosterone problem. Common alternatives to evaluate include:
- Sleep apnea or poor sleep
- Thyroid disease
- Depression, anxiety or burnout
- Alcohol use
- Obesity or major weight change
- Medicines that can affect hormones or energy
If you're still considering sermorelin, go in clear-eyed:
- The best small controlled study in our table (Vittone 2) found no change in body composition after six weeks. Two of six strength measures improved, plus one endurance measure.
- The human studies we reviewed used injections. Evidence from injected GHRH cannot simply be assumed to apply to tablets, troches or multi-peptide blends.
- A low IGF-1 number alone usually does not diagnose adult growth-hormone deficiency. The Endocrine Society says confirmation usually requires a stimulation test unless a recognized exception applies 14.
- Athletes need to check anti-doping rules. WADA's prohibited list includes GHRH and its analogues such as sermorelin, and testosterone is also prohibited without an applicable therapeutic-use exemption 26.
If you are considering compounded sermorelin, ask for the exact ingredient, dosage form, pharmacy, reason it is being prescribed, monitoring plan, full cost and stopping rule before paying.
Does the 2027 telehealth deadline change anything?
It matters to online testosterone prescribing because testosterone is a Schedule III controlled substance. DEA and HHS extended the current federal telemedicine flexibilities for prescribing controlled medications through December 31, 2026 13. State law and other federal requirements still apply.
Sermorelin is not federally scheduled as a controlled substance, so that DEA controlled-substance deadline is not the rule governing it. But sermorelin still requires lawful prescribing and dispensing, and state telehealth, medical-practice and pharmacy rules can still matter.
What happens after December 31, 2026 depends on whether federal regulators extend the temporary rule again or implement a different permanent framework.
If you're starting TRT online now, ask the program: "What happens to my prescription if the federal telemedicine rule changes after December 31, 2026?"
This is not a reason to panic or rush. It's a reason to know the continuity-of-care plan.
8 questions to ask before you pay for sermorelin or TRT
Get these answers before you pay — in writing if you can. They work for sermorelin, TRT or both. They turn a sales pitch into a decision you can check.
- What problem are we treating, and how was it confirmed? Which symptoms, tests and dates?
- What exact drug am I getting? Name, form, strength, manufacturer or compounder, and pharmacy. Is the finished product FDA-approved or compounded?
- What result will show it's working, and when will we check? A symptom, a lab, or both?
- Which labs are required before and during treatment? For TRT, ask specifically how repeat early-morning testosterone testing and safety labs are handled.
- How could this affect my fertility? What care route should I use if I want children?
- What's the full first-year cost? Membership, medication, testing, consultations, supplies and shipping.
- What's the minimum commitment, and how do I pause or cancel?
- Can I get copies of my labs and records? And for online TRT, what happens if federal or state telemedicine rules change?
Screenshot this list. Bring it to your appointment.
How we checked this comparison
We traced medical and regulatory claims to original studies, FDA records, DEA material and specialty-society guidance. We checked current provider prices and policies on provider-owned pages on October 23, 2026, then recalculated the year-one examples ourselves.
Our process follows How We Review TRT Providers. For this page, that meant:
- Reading the studies themselves, not repeating clinic summaries.
- Tracing the disputed testosterone claim back to a study in men already receiving testosterone and multiple peptides.
- Checking the FDA record for Geref's approvals, discontinuation and withdrawal history.
- Separating FDA-approved testosterone from compounded testosterone and compounded sermorelin.
- Using the official DEA extension for the December 31, 2026 controlled-substance telemedicine date.
- Rechecking provider prices instead of carrying forward stale September or older figures.
- Calculating year-one cost from the published inputs and showing the arithmetic.
- Labeling what we didn't do. We did not enroll as patients, submit intake answers, complete checkout, contact clinicians or receive medication.
TRT Provider Guide is not a clinic, pharmacy, laboratory or medical practice. This page has not been reviewed by a clinician. If we find an error, we correct it and update the verification date.
Sermorelin vs testosterone: other questions people ask
Is sermorelin "natural TRT"?
No. Sermorelin targets the growth-hormone pathway, not testosterone replacement. Calling it "natural TRT" blurs two different treatments and two different evidence bases.
Does sermorelin shut down your own testosterone like TRT can?
Sermorelin is not designed to replace testosterone, and the studies we reviewed do not establish that it suppresses testosterone production. But that does not mean it treats low testosterone either.
How long does sermorelin take to raise testosterone?
There is no evidence-based timeline because the studies we found do not establish that sermorelin alone raises testosterone in men.
Does a low IGF-1 mean I need sermorelin?
No. A low IGF-1 result by itself usually does not confirm adult growth-hormone deficiency. The Endocrine Society says stimulation testing is usually required unless a recognized exception applies 14.
Are sermorelin tablets, troches and peptide blends backed by the same studies?
No. The human studies in our evidence table used injected GHRH or GHRH analogs, and the 2017 combination study used multiple peptides. Results from one molecule or dosage form cannot automatically be applied to another.
Do you need a prescription for compounded sermorelin?
Legitimate compounded sermorelin is prepared and dispensed under applicable prescription and compounding law for an identified patient or permitted clinical use. Avoid products sold only as "research use" material for self-treatment.
Is sermorelin banned in sports?
WADA's prohibited list includes growth-hormone-releasing hormone and its analogues, including sermorelin, under prohibited peptide hormones and growth factors. Testosterone is also a prohibited anabolic agent in tested sport 26.
Will insurance cover sermorelin or TRT?
Coverage depends on the plan, diagnosis, product and pharmacy benefit. FDA-approved testosterone products may be covered when plan criteria are met, sometimes with prior authorization. The compounded sermorelin programs reviewed on this page are cash-pay.
Can women use this comparison?
This page covers adult men being evaluated for testosterone deficiency. Women's hormone care follows different evidence and treatment standards, so this page should not be used as a treatment guide for women.
The short version: sermorelin is not an established testosterone treatment. If low testosterone is properly confirmed, TRT may be one treatment to discuss after the cause, risks and fertility plans are evaluated. If not, your next step may be repeat testing, a specialist, or a clearer look at what a sermorelin program is actually offering.
Find My TRT Path is educational and non-diagnostic. It does not diagnose low testosterone, clear contraindications or guarantee a prescription.
Still not sure which TRT care route fits you? Use our free Find My TRT Path tool.
Sources
- Corpas E, et al. Growth hormone-releasing hormone-(1-29) twice daily reverses the decreased GH and IGF-I levels in old men. J Clin Endocrinol Metab. 1992. https://pubmed.ncbi.nlm.nih.gov/1379256/
- Vittone J, et al. Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men. Metabolism. 1997;46(1):89-96. https://pubmed.ncbi.nlm.nih.gov/9005976/
- Khorram O, et al. Endocrine and metabolic effects of long-term administration of [Nle27]GHRH-(1-29)-NH2 in age-advanced men and women. J Clin Endocrinol Metab. 1997;82(5):1472-1479. https://pubmed.ncbi.nlm.nih.gov/9141536/
- Sigalos JT, et al. Growth hormone secretagogue treatment in hypogonadal men raises serum insulin-like growth factor-1 levels. Am J Mens Health. 2017;11(6):1752-1757. https://pubmed.ncbi.nlm.nih.gov/28830317/
- Chatelain PG, Sanchez P, Saez JM. Growth hormone and insulin-like growth factor I treatment increase testicular luteinizing hormone receptors and steroidogenic responsiveness of growth hormone deficient dwarf mice. Endocrinology. 1991;128(4):1857-1862. https://pubmed.ncbi.nlm.nih.gov/2004605/
- Sinha DK, et al. Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. Transl Androl Urol. 2020;9(Suppl 2):S149-S159. https://tau.amegroups.org/article/view/33160/html
- American Urological Association. Evaluation and Management of Testosterone Deficiency. Validity confirmed 2024. https://www.auanet.org/guidelines-and-quality/guidelines/testosterone-deficiency-guideline
- Endocrine Society. Statement on Testosterone Replacement Therapy. July 16, 2026. https://www.endocrine.org/news-and-advocacy/news-room/2026/statement-on-testosterone-replacement-therapy
- U.S. Food and Drug Administration. Determination That GEREF (Sermorelin Acetate) Injection Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness. Federal Register. March 4, 2013. https://www.govinfo.gov/content/pkg/FR-2013-03-04/html/2013-04827.htm
- U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- Drug Enforcement Administration. Drug Scheduling. https://www.dea.gov/drug-information/drug-scheduling
- Crosnoe LE, Grober E, Ohl D, Kim ED. Exogenous testosterone: a preventable cause of male infertility. Transl Androl Urol. 2013. https://pmc.ncbi.nlm.nih.gov/articles/PMC4708215/
- Drug Enforcement Administration. DEA Extends Telemedicine Flexibilities to Ensure Continued Access to Care. December 31, 2025. https://www.dea.gov/press-releases/2025/12/31/dea-extends-telemedicine-flexibilities-ensure-continued-access-care
- Endocrine Society. Evaluation and Treatment of Adult Growth Hormone Deficiency. 2011. https://www.endocrine.org/clinical-practice-guidelines/adult-growth-hormone-deficiency
- Office of Information and Regulatory Affairs. RIN 0910-ZD94, Interim Access Policy for Compounding Using Certain Peptides. Received October 14, 2026; pending review on verification date. https://www.reginfo.gov/public/do/eoReviewSearch?rin=0910-ZD94
- Endocrine Society. Hormones and Aging: An Endocrine Society Scientific Statement. 2023. https://www.endocrine.org/news-and-advocacy/news-room/2023/endocrine-society-scientific-statement-distinguishes-normal-aging-from-endocrine-disease
- U.S. Food and Drug Administration. FDA issues class-wide labeling changes for testosterone products. February 28, 2025. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-issues-class-wide-labeling-changes-testosterone-products
- U.S. Department of Health and Human Services. HHS Announces Requested Updates to Testosterone Therapy Product Labels. June 18, 2026. https://www.hhs.gov/press-room/fda-requests-updates-testosterone-therapy-labeling.html
- Hone Health. Membership Overview: Basic, Plus & Premium Plans. Checked October 23, 2026. https://help.honehealth.com/hc/en-us/articles/40161781101335-Hone-Health-Membership-Overview-Compare-Basic-Plus-Premium-Plans
- Hone Health. Hone Plus Membership: Men's Hormone Optimization with Labs. Checked October 23, 2026. https://help.honehealth.com/hc/en-us/articles/40162110574103-Hone-Plus-Membership-Men-s-Hormone-Optimization-with-Labs
- Hone Health. Hone Premium Membership: Full Clinical Insight for Men. Checked October 23, 2026. https://help.honehealth.com/hc/en-us/articles/40162141159319-Hone-Premium-Membership-Full-Clinical-Insight-for-Men
- Hone Health. How Async Care Works at Hone; Basic Membership treatment pricing. Checked October 23, 2026. https://help.honehealth.com/hc/en-us/articles/43370687967895-How-Async-Care-Works-at-Hone
- Male Excel. Testosterone Treatment Pricing. Checked October 23, 2026. https://maleexcel.com/treatments/hrt-costs/
- Taurus Meds. Homepage. Checked October 23, 2026. https://taurusmeds.com/
- Male Excel. Homepage and FAQ. Checked October 23, 2026. https://maleexcel.com/
- World Anti-Doping Agency. Prohibited List. 2026 list, class S1/S2. https://www.wada-ama.org/en/prohibited-list